HLA-C and neoplasm: Efficient adaptive responses against cancer occur typically in secondary lymphoid organs (SLOs), wherein major histocompatibility complex (MHC) molecule–peptide complexes are presented by dendritic cells (DCs) to T-cells, and require the migration of DCs from the tumor site to the SLOs [65].